Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOMERIEUX INC
Awarding agency: Department of Defense / Department of the Navy
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-19 to 2023-09-27
Current total value of award: $9404.04
Description: AMPICILLIN AM 256 US S30 BENZYLPENICILLIN PGL US S30 CEFTAZIDIME TZ 256 US S30 CEFTRIAXONE TX 256 US S30 DAPTOMYCIN DPC 256 US S30 LEVOFLOXACIN LE 32 US S30 LINEZOLID LZ 256 US S30 OXACILLIN